Management of Asrigdara with Shudda gairika

A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHUDDA GAIRIKA IN THE MANAGEMENT OF ASRIGDARA W.S.R TO MENORRHAGIA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024201

Enrollment

Registered

2020-03-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: SHUDDA GAIRIKA: 500MG OD WITH MILK Control Intervention1: PUSHYANUGA CHURNA: 6GM BD WITH TANDULODAKA

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients aged between 21-45 years 2 Patients with classical signs of asrigdara i.e, Excessive blood loss during menstruation Prolonged blood loss during menstruation 3 Patients with menorrhagia i.e, Bleeding more than 7days Excess in amount ( >80ml) Or both

Exclusion criteria

Exclusion criteria: 1 Patients with IUCD 2 Polyp 3 Fibroid 4 Post menopausal bleeding 5 Coagulatory disorder 6 Bleeding due to abortion •Pregnancy

Design outcomes

Primary

Measure	Time frame
HEMOSTASISTimepoint: 1 MONTH	—

Secondary

Measure	Time frame
IMPROVEMENT IN HEMOGLOBIN PERCENTAGETimepoint: 1 MONTH	—

Countries

India

Contacts

Public ContactDr Anitha M

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH HOSPITAL

anithamandayam@gmail.com9449805646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026